ARK Fintech Innovation ETF vs Medpace Holdings Inc — how do they compare? ARK Fintech Innovation ETF trades at $43.07, while Medpace Holdings Inc trades at $597.5 (market cap $16.90B). The key difference: Medpace Holdings Inc is trading nearer its 52-week high, ARK Fintech Innovation ETF nearer its low. Which is the better fit depends on your goals.
| ARKF | MEDP | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $58.82 | $620.59 |
52-Week Low | $36.14 | $393.42 |
Market Cap | — | $16.90B |
Enterprise Value | — | $16.52B |
Trailing returns across standard periods
Latest headlines on both assets
ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.
Read more on ARKF →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →